Conventional antepartum fetal monitoring was performed mostly through the mother’s experience and judgment of fetal movements. Heart sounds were monitored through a fetal stethoscope as well. As technology evolved within this market, phonocardiographs (PCG), with the use of sensors, were developed to electronically monitor fetal heart rate (FHR) at a more accurate level. Antepartum monitoring includes non-stress tests as well as the contraction stress tests. The main purpose of intrapartum fetal monitoring is to monitor FHR in order to assess brain injury. Antepartum monitoring may occur in the hospital or private practice setting. Intrapartum monitoring during labor is important as severe complications such as brain damage can occur. This type of monitoring occurs in the hospital labor ward. A cardiotocograph (CTG) monitors FHR, beat-to-beat, as well as uterine contractions in order to properly monitor for brain injury. This technique utilizes ultrasound probes or an external contraction sensor. Invasive techniques allow the physician direct exposure to intra-uterine pressure, and are performed using a catheter-tipped pressure sensor or an external transducer connected to a water-filled cannula. Monitors with ST waveform analysis capabilities allow physicians to analyze fetal electrocardiographs (ECG) in addition to heart rate. Neonatal monitoring includes high-acuity neonates that are typically monitored in a neonatal intensive care unit (NICU). Neonate patients most commonly result from premature births and require access to specialized equipment and resources such as temperature support, feeding, respiratory assistance and isolation to prevent infection. Neonatal monitors are standard high-acuity monitors that employ specialized algorithms, different alarm limits and measurements as well as an event and alerting packages specific to neonates. In less critical cases, neonate patients may be monitored in low-acuity settings, often using pulse oximetry. Both fetal and neonatal monitoring may be done invasively and non-invasively. Each method has advantages and disadvantages. Invasive methods for fetal monitoring have traditionally been used and are able to directly reveal genetic abnormalities in the fetus. Invasive monitoring is often believed to be more accurate than non-invasive methods; however, complications can occur. Invasive techniques may cause damage to fetal and maternal tissues, as well as trauma, pain and in some cases, miscarriage. The advantages of non-invasive techniques are significant ranging from decreased trauma, pain and tissue damage, to lower costs for patients.
Neonatal monitoring is shifting toward more non-invasive methods. Due to small patient size, invasive techniques are usually harmful and damaging to the patient. Recent advances in monitoring technologies allow for a greater number of physiological parameters to be monitored non-invasively such as blood gas, cerebral blood flow, EEG, end tidal CO2 and biochemical characteristics.
'
TABLE OF CONTENTS I
LIST OF FIGURES V
LIST OF CHARTS VII
SUITE EXECUTIVE SUMMARY 1
EUROPEAN PATIENT MONITORING MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 11
MARKETS INCLUDED 13
KEY REPORT UPDATES 15
VERSION HISTORY 16
RESEARCH METHODOLOGY 17
1.1 RESEARCH SCOPE 17
1.2 IDATA’S 9-STEP METHODOLOGY 17
Step 1: Project Initiation & Team Selection 17
Step 2: Prepare Data Systems and Perform Secondary Research 19
Step 3: Preparation for Interviews & Questionnaire Design 20
Step 4: Performing Primary Research 21
Step 5: Research Analysis: Establishing Baseline Estimates 23
Step 6: Market Forecast and Analysis 24
Step 7: Identify Strategic Opportunities 26
Step 8: Final Review and Market Release 27
Step 9: Customer Feedback and Market Monitoring 28
COUNTRY PROFILES 29
2.1 INTRODUCTION 29
2.1.1.1 Population 29
2.1.1.2 Median Age 29
2.1.1.3 GDP Per Capita 29
2.1.1.4 Price Index 29
2.2 GERMANY 31
2.3 FRANCE 32
2.4 UNITED KINGDOM 33
2.5 ITALY 34
2.6 SPAIN 35
2.7 BENELUX 36
2.8 SCANDINAVIA 37
2.9 AUSTRIA 38
2.10 SWITZERLAND 39
2.11 PORTUGAL 40
FETAL AND NEONATAL MONITORING MARKET 41
3.1 INTRODUCTION 41
3.1.1 Fetal Monitoring 41
3.1.2 Neonatal Monitoring 42
3.1.3 Invasive and Non-Invasive Monitoring 42
3.2 MARKET OVERVIEW 43
3.3 MARKET ANALYSIS AND FORECAST 47
3.3.1 Fetal Monitor Market 47
3.3.2 Neonatal Monitor Market 55
3.4 DRIVERS AND LIMITERS 63
3.4.1 Market Drivers 63
3.4.2 Market Limiters 64
3.5 COMPETITIVE MARKET SHARE ANALYSIS 65
ABBREVIATIONS 69
Chart 1 1: Patient Monitoring Market by Segment, Europe, 2012 – 2022 3
Chart 1 2: Patient Monitoring Market Overview, Europe, 2012 & 2022 3
Chart 2 1: Country Profile, Germany, 2015 31
Chart 2 2: Country Profile, France, 2015 32
Chart 2 3: Country Profile, United Kingdom, 2015 33
Chart 2 4: Country Profile, Italy, 2015 34
Chart 2 5: Country Profile, Spain, 2015 35
Chart 2 6: Country Profile, Benelux, 2015 36
Chart 2 7: Country Profile, Scandinavia, 2015 37
Chart 2 8: Country Profile, Austria, 2015 38
Chart 2 9: Country Profile, Switzerland, 2015 39
Chart 2 10: Country Profile, Portugal, 2015 40
Chart 3 1: Fetal and Neonatal Monitoring Market by Segment, Europe, 2012 – 2022 45
Chart 3 2: Fetal and Neonatal Monitoring Market Breakdown, Europe, 2015 46
Chart 3 3: Fetal and Neonatal Monitoring Market Breakdown, Europe, 2022 46
Chart 3 4: Fetal Monitor Market, Europe, 2012 – 2022 49
Chart 3 5: Neonatal Monitor Market, Europe, 2012 – 2022 57
Chart 3 6: Leading Competitors, Fetal and Neonatal Monitoring Market, Europe, 2015 68
Figure 1 1: Patient Monitoring Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 2) 5
Figure 1 2: Patient Monitoring Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 2) 5
Figure 1 3: Companies Researched in this Report, Europe, 2015 6
Figure 1 4: Factors Impacting the Patient Monitoring Market by Segment, Europe (1 of 4) 7
Figure 1 5: Factors Impacting the Patient Monitoring Market by Segment, Europe (2 of 4) 8
Figure 1 6: Factors Impacting the Patient Monitoring Market by Segment, Europe (3 of 4) 9
Figure 1 7: Factors Impacting the Patient Monitoring Market by Segment, Europe (4 of 4) 10
Figure 1 8: Recent Events in the Patient Monitoring Market, Europe, 2012 – 2015 (1 of 2) 11
Figure 1 9: Recent Events in the Patient Monitoring Market, Europe, 2012 – 2015 (2 of 2) 12
Figure 1 10: Patient Monitoring Markets Covered, Europe, 2015 (1 of 2) 13
Figure 1 11: Patient Monitoring Markets Covered, Europe, 2015 (2 of 2) 14
Figure 1 12: Key Report Updates 15
Figure 1 13: Version History 16
Figure 3 1: Fetal and Neonatal Monitoring Market by Segment, Europe, 2012 – 2022 (€M) 44
Figure 3 2: Fetal and Neonatal Monitoring Market by Segment, Europe, 2012 – 2022 (US$M) 44
Figure 3 3: Fetal Monitor Market, Europe, 2012 – 2022 (€ and US$) 48
Figure 3 4: Units Sold by Country, Fetal Monitor Market, Europe, 2012 – 2022 50
Figure 3 5: Average Selling Price by Country, Fetal Monitor Market, Europe, 2012 – 2022 (€) 51
Figure 3 6: Average Selling Price by Country, Fetal Monitor Market, Europe, 2012 – 2022 (US$) 52
Figure 3 7: Market Value by Country, Fetal Monitor Market, Europe, 2012 – 2022 (€M) 53
Figure 3 8: Market Value by Country, Fetal Monitor Market, Europe, 2012 – 2022 (US$M) 54
Figure 3 9: Neonatal Monitor Market, Europe, 2012 – 2022 (€ and US$) 56
Figure 3 10: Units Sold by Country, Neonatal Monitor Market, Europe, 2012 – 2022 58
Figure 3 11: Average Selling Price by Country, Neonatal Monitor Market, Europe, 2012 – 2022 (€) 59
Figure 3 12: Average Selling Price by Country, Neonatal Monitor Market, Europe, 2012 – 2022 (US$) 60
Figure 3 13: Market Value by Country, Neonatal Monitor Market, Europe, 2012 – 2022 (€M) 61
Figure 3 14: Market Value by Country, Neonatal Monitor Market, Europe, 2012 – 2022 (US$M) 62
Figure 3 15: Drivers and Limiters, Fetal and Neonatal Monitoring Market, Europe, 2015 64
Figure 3 16: Leading Competitors by Segment, Fetal and Neonatal Monitoring Market, Europe, 2015 68
Philips Healthcare
GE Healthcare
Dräger Medical
Huntleigh
Mindray Medical
Neoventa
Edan Instruments
